Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has earned a consensus rating of "Moderate Buy" from the ten ratings firms that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $47.94.
ACHC has been the subject of a number of recent research reports. Barclays cut their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a report on Wednesday, May 14th. KeyCorp cut their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Guggenheim started coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price target for the company. Finally, Mizuho cut their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a report on Wednesday, May 14th.
Check Out Our Latest Stock Analysis on ACHC
Hedge Funds Weigh In On Acadia Healthcare
A number of hedge funds have recently made changes to their positions in the stock. Wellington Management Group LLP boosted its position in shares of Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock worth $465,283,000 after purchasing an additional 76,490 shares during the period. FMR LLC boosted its position in shares of Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP boosted its position in Acadia Healthcare by 18.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after buying an additional 486,395 shares during the period. Hawk Ridge Capital Management LP boosted its position in Acadia Healthcare by 437.5% in the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock valued at $74,988,000 after buying an additional 2,013,126 shares during the period. Finally, Citigroup Inc. boosted its position in Acadia Healthcare by 5,144.2% in the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock valued at $72,047,000 after buying an additional 2,330,898 shares during the period.
Acadia Healthcare Price Performance
Acadia Healthcare stock traded down $0.57 during midday trading on Tuesday, reaching $22.20. The company had a trading volume of 445,570 shares, compared to its average volume of 1,856,535. The company has a market capitalization of $2.05 billion, a P/E ratio of 10.92, a P/E/G ratio of 4.32 and a beta of 0.93. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.41. The firm's fifty day simple moving average is $23.11 and its 200-day simple moving average is $30.32. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. Acadia Healthcare's quarterly revenue was up .3% compared to the same quarter last year. During the same period last year, the company posted $0.84 EPS. As a group, equities analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.
About Acadia Healthcare
(
Get Free ReportAcadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.